KBC Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,159
| Closed | -$63K | – | 1719 |
|
2025
Q1 | $63K | Hold |
2,159
| – | – | ﹤0.01% | 1718 |
|
2024
Q4 | $80K | Buy |
2,159
+650
| +43% | +$24.1K | ﹤0.01% | 1677 |
|
2024
Q3 | $73K | Hold |
1,509
| – | – | ﹤0.01% | 1490 |
|
2024
Q2 | $60K | Buy |
1,509
+538
| +55% | +$21.4K | ﹤0.01% | 1507 |
|
2024
Q1 | $43K | Hold |
971
| – | – | ﹤0.01% | 1629 |
|
2023
Q4 | $60K | Sell |
971
-131
| -12% | -$8.1K | ﹤0.01% | 1385 |
|
2023
Q3 | $51K | Sell |
1,102
-1,668
| -60% | -$77.2K | ﹤0.01% | 1426 |
|
2023
Q2 | $159K | Sell |
2,770
-408
| -13% | -$23.4K | ﹤0.01% | 1010 |
|
2023
Q1 | $119K | Hold |
3,178
| – | – | ﹤0.01% | 1149 |
|
2022
Q4 | $89K | Hold |
3,178
| – | – | ﹤0.01% | 1247 |
|
2022
Q3 | $89K | Hold |
3,178
| – | – | ﹤0.01% | 1229 |
|
2022
Q2 | $111K | Buy |
+3,178
| New | +$111K | ﹤0.01% | 1189 |
|
2020
Q1 | – | Sell |
-42,019
| Closed | -$811K | – | 1287 |
|
2019
Q4 | $811K | Hold |
42,019
| – | – | 0.01% | 956 |
|
2019
Q3 | $833K | Hold |
42,019
| – | – | 0.01% | 930 |
|
2019
Q2 | $887K | Sell |
42,019
-13,588
| -24% | -$287K | 0.01% | 891 |
|
2019
Q1 | $1.14M | Hold |
55,607
| – | – | 0.01% | 820 |
|
2018
Q4 | $1.11M | Sell |
55,607
-16,046
| -22% | -$319K | 0.01% | 717 |
|
2018
Q3 | $1.38M | Buy |
71,653
+7,782
| +12% | +$150K | 0.01% | 812 |
|
2018
Q2 | $975K | Buy |
63,871
+2,630
| +4% | +$40.1K | 0.01% | 814 |
|
2018
Q1 | $1.15M | Buy |
61,241
+15,225
| +33% | +$285K | 0.01% | 735 |
|
2017
Q4 | $885K | Hold |
46,016
| – | – | 0.01% | 841 |
|
2017
Q3 | $822K | Hold |
46,016
| – | – | 0.01% | 858 |
|
2017
Q2 | $822K | Hold |
46,016
| – | – | 0.01% | 840 |
|
2017
Q1 | $667K | Buy |
46,016
+16,460
| +56% | +$239K | 0.01% | 982 |
|
2016
Q4 | $544K | Buy |
+29,556
| New | +$544K | 0.01% | 1014 |
|